Table of Contents
ISRN Endocrinology
Volume 2012, Article ID 675310, 8 pages
http://dx.doi.org/10.5402/2012/675310
Research Article

Long-Term Health-Related Quality of Life of Surgically Treated Pituitary Adenoma Patients: A Descriptive Study

1Department of Otorhinolaryngology-Head & Neck Surgery, Institute of Clinical Medicine, University of Oulu, Oulu, Finland
2Department of Otorhinolaryngology, Lapland Central Hospital, Rovaniemi, Finland
3Institute of Clinical Medicine, Faculty of Medicine, University of Oulu, Oulu, Finland
4Department of Public Health, Hjelt Institute, University of Helsinki, Helsinki, Finland
5Department of Neurosurgery, Institute of Clinical Medicine, University of Oulu, Oulu, Finland

Received 23 October 2012; Accepted 13 November 2012

Academic Editors: F. L. Forti and K. Hull

Copyright © 2012 A. Raappana et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Raappana, J. Koivukangas, T. Ebeling, and T. Pirilä, “Incidence of pituitary adenomas in Northern Finland in 1992–2007,” Journal of Clinical Endocrinology and Metabolism, vol. 95, no. 9, pp. 4268–4275, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Santos, E. Resmini, M. A. Martínez, C. Martí, J. Ybarra, and S. M. Webb, “Quality of life in patients with pituitary tumors,” Current Opinion in Endocrinology, Diabetes and Obesity, vol. 16, no. 4, pp. 299–303, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. R. A. Feelders, S. J. Pulgar, A. Kempel, and A. M. Pereira, “The burden of Cushing's disease: clinical and health-related quality of life aspects,” European Journal of Endocrinology, vol. 167, no. 3, pp. 311–326, 2012. View at Publisher · View at Google Scholar
  4. S. J. C. M. M. Neggers, M. O. van Aken, W. W. de Herder et al., “Quality of life in acromegalic patients during long-term somatostatin analog treatment with and without pegvisomant,” Journal of Clinical Endocrinology and Metabolism, vol. 93, no. 10, pp. 3853–3859, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. S. C. Hua, Y. H. Yan, and T. C. Chang, “Associations of remission status and lanreotide treatment with quality of life in patients with treated acromegaly,” European Journal of Endocrinology, vol. 155, no. 6, pp. 831–837, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. N. R. Biermasz, S. W. van Thiel, A. M. Pereira et al., “Decreased quality of life in patients with acromegaly despite long-term cure of growth hormone excess,” Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 11, pp. 5369–5376, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. M. P. Matta, E. Couture, L. Cazals, D. Vezzosi, A. Bennet, and P. Caron, “Impaired quality of life of patients with acromegaly: control of GH/IGF-I excess improves psychological subscale appearance,” European Journal of Endocrinology, vol. 158, no. 3, pp. 305–310, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. N. F. Marko, E. Lasota, A. H. Hamrahian, and R. J. Weil, “Comparative effectiveness review of treatment options for pituitary microadenomas in acromegaly: clinical article,” Journal of Neurosurgery, vol. 117, no. 3, pp. 522–538, 2012. View at Publisher · View at Google Scholar
  9. M. D. Johnson, C. J. Woodburn, and M. L. Vance, “Quality of life in patients with a pituitary adenoma,” Pituitary, vol. 6, no. 2, pp. 81–87, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. A. A. van der Klaauw, M. Kars, N. R. Biermasz et al., “Disease-specific impairments in quality of life during long-term follow-up of patients with different pituitary adenomas,” Clinical Endocrinology, vol. 69, no. 5, pp. 775–784, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. E. H. Nielsen, J. Lindholm, P. Laurberg et al., “Nonfunctioning pituitary adenoma: incidence, causes of death and quality of life in relation to pituitary function,” Pituitary, vol. 10, no. 1, pp. 67–73, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. R. C. L. Page, M. S. Hammersley, C. W. Burke, and J. A. H. Wass, “An account of the quality of life of patients after treatment for non- functioning pituitary tumours,” Clinical Endocrinology, vol. 46, no. 4, pp. 401–406, 1997. View at Google Scholar · View at Scopus
  13. H. Sintonen, “The 15D instrument of health-related quality of life: properties and applications,” Annals of Medicine, vol. 33, no. 5, pp. 328–336, 2001. View at Google Scholar · View at Scopus
  14. A. Giustina, A. Barkan, F. F. Casanueva et al., “Criteria for cure of acromegaly: a consensus statement,” Journal of Clinical Endocrinology and Metabolism, vol. 85, no. 2, pp. 526–529, 2000. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Aromaa and S. Koskinen, Eds., Health and Functional Capacity in Finland. Baseline Results of the Health 2000 Health Examination Survey, vol. B12-2004, The National Public Health Institute, Helsinki, Finland, 2004.
  16. K. Stavem, “Reliability, validity and responsiveness of two multiattribute utility measures in patients with chronic obstructive pulmonary disease,” Quality of Life Research, vol. 8, no. 1-2, pp. 45–54, 1999. View at Publisher · View at Google Scholar · View at Scopus
  17. G. Hawthorne, J. Richardson, and N. A. Day, “A comparison of the Assessment of Quality of Life (AQoL) with four other generic utility instruments,” Annals of Medicine, vol. 33, no. 5, pp. 358–370, 2001. View at Google Scholar · View at Scopus
  18. J. Moock and T. Kohlmann, “Comparing preference-based quality-of-life measures: Results from rehabilitation patients with musculoskeletal, cardiovascular, or psychosomatic disorders,” Quality of Life Research, vol. 17, no. 3, pp. 485–495, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. R. Kauppinen-Mäkelin, T. Sane, H. Sintonen et al., “Quality of life in treated patients with acromegaly,” Journal of Clinical Endocrinology and Metabolism, vol. 91, no. 10, pp. 3891–3896, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. E. Cesar de Oliveira Naliato, A. H. Dutra Violante, D. Caldas et al., “Quality of life in women with microprolactinoma treated with dopamine agonists,” Pituitary, vol. 11, no. 3, pp. 247–254, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. O. M. Dekkers, A. M. Pereira, F. Roelfsema et al., “Observation alone after transsphenoidal surgery for nonfunctioning pituitary macroadenoma,” Journal of Clinical Endocrinology and Metabolism, vol. 91, no. 5, pp. 1796–1801, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. O. M. Dekkers, A. A. van der Klaauw, A. M. Pereira et al., “Quality of life is decreased after treatment for nonfunctioning pituitary macroadenoma,” Journal of Clinical Endocrinology and Metabolism, vol. 91, no. 9, pp. 3364–3369, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. P. Burman, J. E. Broman, J. Hetta et al., “Quality of life in adults with growth hormone (GH) deficiency: response to treatment with recombinant human GH in a placebo-controlled 21-month trial,” Journal of Clinical Endocrinology and Metabolism, vol. 80, no. 12, pp. 3585–3590, 1995. View at Publisher · View at Google Scholar · View at Scopus
  24. M. E. Molitch, “Pituitary incidentalomas,” Best Practice & Research Clinical Endocrinology & Metabolism, vol. 23, no. 5, pp. 667–675, 2009. View at Publisher · View at Google Scholar · View at Scopus